CH
CVI Holdings Portfolio holdings
AUM
$116M
This Quarter Return
-13.26%
1 Year Return
+3.84%
3 Year Return
+23.84%
5 Year Return
+272.82%
10 Year Return
–
AUM
$86.6M
AUM Growth
+$86.6M
(-18%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-13.01%
Top 10 Holdings %
Top 10 Hldgs %
77.72%
Holding
92
New
34
Increased
1
Reduced
9
Closed
28
Top Buys
| 1 |
Comscore
SCOR
|
$14.1M |
| 2 |
Carisma Therapeutics
CARM
|
$12.2M |
| 3 |
MDCO
Medicines Co
MDCO
|
$4.12M |
| 4 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$3.74M |
| 5 |
CALA
Calithera Biosciences, Inc
CALA
|
$3.29M |
Top Sells
| 1 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$18.5M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$16M |
| 3 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$8.16M |
| 4 |
GNFT
Genfit
GNFT
|
$5.17M |
| 5 |
Spyre Therapeutics
SYRE
|
$2.19M |
Sector Composition
| 1 | Healthcare | 33.38% |
| 2 | Communication Services | 20.11% |
| 3 | Consumer Staples | 4.12% |
| 4 | Industrials | 1.28% |
| 5 | Consumer Discretionary | 0.71% |
